Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nkarta, Inc.
Hoffmann-La Roche
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Eli Lilly and Company
Ohio State University Comprehensive Cancer Center
AIDS Malignancy Consortium
Verismo Therapeutics
Incyte Corporation
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Baylor College of Medicine
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
TCRx Therapeutics Co.Ltd
Janssen Research & Development, LLC
Conjupro Biotherapeutics, Inc.
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Arovella Therapeutics Ltd
University of Arizona
British Columbia Cancer Agency
Weill Medical College of Cornell University
Novartis
Pfizer
iOnctura
City of Hope Medical Center
Treeline Biosciences, Inc.